Interferon for the treatment of genital warts: a systematic review
J Yang, Y Pu, Z Zeng, Z Yu, N Huang, Q Deng - BMC Infectious Diseases, 2009 - Springer
Background Interferon has been widely used in the treatment of genital warts for its
immunomodulatory, antiproliferative and antiviral properties. Currently, no evidence that …
immunomodulatory, antiproliferative and antiviral properties. Currently, no evidence that …
Adjuvant treatment of anogenital warts with systemic interferon: a systematic review and meta-analysis
L Westfechtel, RN Werner, C Dressler… - Sexually Transmitted …, 2018 - sti.bmj.com
Background Interferons are natural messenger proteins that are used to treat various
disease entities. Due to their immunomodulating, antiviral and antiproliferative effects, the …
disease entities. Due to their immunomodulating, antiviral and antiproliferative effects, the …
A guide to immunotherapy of genital warts: focus on interferon and imiquimod
AJ Czelusta, T Evans, I Arany, SK Tyring - BioDrugs, 1999 - Springer
Genital warts affect at least 1% of sexually active adults. Current therapies are inadequate
because they are often painful, may fail to prevent recurrence and transmission of warts, and …
because they are often painful, may fail to prevent recurrence and transmission of warts, and …
Imiquimod for the treatment of genital warts: a quantitative systematic review
RA Moore, JE Edwards, J Hopwood, D Hicks - BMC Infectious Diseases, 2001 - Springer
Objective To review published randomised controlled trials to assess the benefit and harm of
imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 …
imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 …
Therapeutic approaches to genital warts
KR Beutner, A Ferenczy - The American journal of medicine, 1997 - Elsevier
Although many treatments are available for genital warts caused by human papillomavirus
(HPV), none are uniformly successful in the treatment of this disease. Most current treatment …
(HPV), none are uniformly successful in the treatment of this disease. Most current treatment …
Combined therapy trial with interferon alpha-2a and ablative therapy in the treatment of anogenital warts.
DK Armstrong, RD Maw, WW Dinsmore… - Sexually Transmitted …, 1996 - sti.bmj.com
OBJECTIVE: To determine whether the combination of systemically administered interferon
alpha-2a and ablative surgery for the treatment of genital and/or perianal warts produces a …
alpha-2a and ablative surgery for the treatment of genital and/or perianal warts produces a …
An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women
SM Garland, R Waddell, A Mindel… - … journal of STD & …, 2006 - journals.sagepub.com
Our objective was to determine the optimal duration of treatment with imiquimod for external
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …
New approach to managing genital warts
CC Lopaschuk - Canadian Family Physician, 2013 - cfp.ca
Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …
management tools for genital warts. Sources of information The following databases were …
Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day
KH Fife, A Ferenczy, JM Douglas Jr… - Sexually transmitted …, 2001 - journals.lww.com
Background Medical therapy for genital warts remains suboptimal. The topical interferon and
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …
Tolerance and efficacy of recombinant human interferon gamma in the treatment of refractory genital warts
PK Kirby, N Kiviat, A Beckman, D Wells… - The American Journal of …, 1988 - Elsevier
Purpose The intralesional administration of recombinant interferon alpha has led to
resolution of genital warts in 50 to 70 percent of cases. However, continguous warts do not …
resolution of genital warts in 50 to 70 percent of cases. However, continguous warts do not …
相关搜索
- treatment of genital warts
- genital warts focus on interferon
- external genital warts in men
- external genital warts in women
- immunotherapy of genital warts
- refractory genital warts
- meta analysis systemic interferon
- meta analysis anogenital warts
- genital warts therapeutic approaches
- meta analysis adjuvant treatment
- anogenital warts systemic interferon
- adjuvant treatment systemic interferon
- anogenital warts ablative therapy
- anogenital warts alpha 2a
- treatment of anogenital warts